دورية أكاديمية

Burden of COVID-19 in córdoba, a department of Colombia: results of disability-adjusted life-years ; Carga de COVID-19 en Córdoba, un departamento de Colombia: resultados de los años de vida ajustados por discapacidad

التفاصيل البيبلوغرافية
العنوان: Burden of COVID-19 in córdoba, a department of Colombia: results of disability-adjusted life-years ; Carga de COVID-19 en Córdoba, un departamento de Colombia: resultados de los años de vida ajustados por discapacidad
المؤلفون: Lozano, Ana, Salcedo Mejía, Fernando, Zakzuk, Josefina, ALVIS ZAKZUK, NELSON RAFAEL, Moyano-Tamara, Lina, Serrano-Coll, Héctor, Gastelbondo, Bertha Irina, Mattar, Salim, ALVIS-ZAKZUK, NELSON J., Alvis-Guzmán, Nelson
المصدر: https://www.sciencedirect.com/science/article/pii/S221210992300033XTest.
بيانات النشر: Elsevier USA
United States
سنة النشر: 2023
المجموعة: REDICUC - Repositorio Universidad de La Costa
مصطلحات موضوعية: Coronavirus infections, Disability-adjusted life-year, Severe acute respiratory syndrome, Years of life lost, Years lived with disability, Años de vida perdidos, Infecciones por coronavirus, Años vividos con discapacidad, Años de vida ajustados por discapacidad
جغرافية الموضوع: Colombia, Córdoba
الوصف: Objectives: This study aimed to estimate the burden of acute COVID-19 in Córdoba, one of the most affected departments (states) in Colombia, through the estimation of disability-adjusted life-years (DALYs). Methods: DALYs were estimated based on the number of cases of severe acute respiratory syndrome coronavirus 2 infection cases reported by official Colombian sources. A transition probability matrix among severity states was calculated using data obtained from a retrospective cohort that included 1736 COVID-19 confirmed subjects living in Córdoba. Results: Córdoba had 120.23 deaths per 100 000 habitants during the study period (March 2020 to April 2021). Estimated total DALYs were 49 243 (2692 DALYs per 100 000 inhabitants), mostly attributed to fatal cases (99.7%). On average, 25 years of life were lost because of death by this infection. A relevant proportion of years of life lost because of COVID-19 (46.6%) was attributable to people , 60 years old and was greater in men. People $ 60 years old showed greater risk of progression to critical state than people between the age of 35 and 60 years (hazard ratio 2.5; 95% confidence interval 2.5-12.5) and younger than 35 years (9.1; 95% confidence interval 4.0-20.6). Conclusion: In Córdoba, premature mortality because of COVID-19 was substantially represented by people , 60 years old and was greater in males. Our data may be representative of Latin American populations with great infection spread during the first year of the pandemic and contribute to novel methodological aspects and parameter estimations that may be useful to measure COVID-19 burden in other countries of the region. ; Objetivos: Estimar la carga de COVID-19 aguda en Córdoba, uno de los departamentos (estados) más afectados de Colombia, a través de la estimación de años de vida ajustados por discapacidad (AVISAS). Métodos: Los AVISAS se estimaron con base en el número de casos de infección por severe acute respiratory syndrome coronavirus 2 reportados por fuentes oficiales colombianas. Se calculó ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: 9 páginas; application/pdf
اللغة: English
تدمد: 2212-1099
2212-1102
العلاقة: Value in Health Regional Issues; 1. La OMS caracteriza a COVID-19 como una pandemia. Organización Panamericana de Salud. https://www.paho.org/hq/index.php?option=com_content&view=article&id=15756:who-characterizes-covid-19-as-a-pandemic&Itemid=1926&lang=esTest. Accessed February 1, 2021.; 2. Ritchie H, Mathieu E, Rodés-Guirao L, et al. Coronavirus pandemic (COVID-19). OurWorldInData. https://ourworldindata.org/coronavirusTest. Accessed August 30, 2022.; 3. Prada SI, Garcia-Garcia MP, Guzman J. COVID-19 response in Colombia: hits and misses. Health Policy Technol. 2022;11(2):100621.; 4. Wang H, Paulson KR, Pease SA. Estimating excess mortality due to the COVID19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513–1536.; 5. Casos de COVID-19 en Colombia. Instituto Nacionald de Salud. https://wwwTest. ins.gov.co/Noticias/Paginas/coronavirus-casos.aspx. Accessed February 27, 2021.; 6. WHO coronavirus (COVID-19) dashboard. World Health Organization. https://covid19.who.int/?adgroupsurveyTest={adgroupsurvey}&gclid=EAIaIQobC hMI4vm_tdSS_gIV8JZLBR0JnA5CEAAYASABEgIFJfD_BwE. Accessed August 30, 2022.; 7. Proyecciones de población departamentales por área. Departamento Administrativo Nacional de Estadística. https://www.dane.gov.co/index.phpTest/ estadisticas-por-tema/demografia-y-poblacion/proyecciones-de-poblacion. Accessed August 30, 2022.; 8. Mattar S, Alvis-Guzman N, Garay E, et al. Severe acute respiratory syndrome coronavirus 2 seroprevalence among adults in a tropical city of the Caribbean area, Colombia: are we much closer to herd immunity than developed countries? Open Forum Infect Dis. 2020;7(12):ofaa550.; 9. John D, Narassima MS, Menon J, Rajesh JG, Banerjee A. Estimation of economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala state. BMJ Open. 2021;11(8):e049619.; 11. Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–457.; 12. Demografía y población. Departamento Administrativo Nacional de Estadística. https://www.dane.gov.co/index.php/estadisticas-por-tema/demografiay-poblacionTest. Accessed August 30, 2022.; 13. Proyecciones de población a 2020. Censo nacional de población y vivienda - CNPV. Departamento Administrativo Nacional de Estadística. https://wwwTest. dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/proye cciones-de-poblacion. Accessed August 30, 2022.; 14. De la Hoz-Restrepo F, Alvis-Zakzuk NJ, De la Hoz-Gomez JF, De la Hoz A, Gómez Del Corral L, Alvis-Guzmán N. Is Colombia an example of successful containment of the 2020 COVID-19 pandemic? A critical analysis of the epidemiological data, March to July 2020. Int J Infect Dis. 2020;99: 522–529.; 15. Global burden of disease study 2019 (GBD 2019) disability weights. Institute for Health Metrics and Evaluation. https://ghdx.healthdata.org/record/ihmedata/gbd-2019-disability-weightsTest. Accessed August 30, 2022.; 16. Sistema de Información de la Protección Social - SISPRO. Portal de Consulta SISPRO. Ministerio de Salud y Protección Social. https://www.sispro.gov.coTest/ Pages/Home.aspx. Accessed August 30, 2022.; 17. Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat. 1978;5(3):141– 150.; 18. Pires SM, Wyper G, Wengler A, et al. Burden of disease of COVID-19: strengthening the collaboration for national studies. Front Public Health. 2022;10:907012.; 19. Hidalgo-Troya A, Rodríguez JM, Rocha-Buelvas A, Urrego-Ricaurte D. Burden of disease of COVID-19 in the department of Nariño, Colombia, 2020-2021. Rev Peru Med Exp Salud Publ. 2022;39(3):281–291.; 20. Fan CY, Fann JC, Yang MC, et al. Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics. J Formos Med Assoc. 2021;120(suppl 1):S106–S117.; 21. Gianino MM, Savatteri A, Politano G, Nurchis MC, Pascucci D, Damiani G. Burden of COVID-19: disability-adjusted life years (DALYs) across 16 European countries. Eur Rev Med Pharmacol Sci. 2021;25(17):5529–5541.; 22. Shindhe SD, Bhat S, Munoli SB. Burden of COVID-19: DALY and productivity loss for Karnataka, India. Indian J Public Health. 2022;66(3):239.; 23. Singh BB, Devleesschauwer B, Khatkar MS, et al. Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020. Sci Rep. 2022;121(1):2454.; 24. Cuschieri S, Calleja N, Devleesschauwer B, Wyper GMA. Estimating the direct COVID-19 disability-adjusted life years impact on the Malta population for the first full year. BMC Public Health. 2021;21(1):1827.; 25. Bhopal SS, Bhopal R. Sex differential in COVID-19 mortality varies markedly by age. Lancet. 2020;396(10250):532–533.; 26. Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Heal. 2020;8:152.; 27. Sobotka T, Brzozowska Z, Muttarak R, Zeman K, di Lego V. Age, gender and COVID-19 infections. Preprint. Posted online May 26, 2020. medRxiv 20111765. https://doi.org/10.1101/2020.05.24.20111765Test; 28. Cruz R, Diz-de Almeida S, López de Heredia M, et al. Novel genes and sex differences in COVID-19 severity. Hum Mol Genet. 2022;31(22):3789–3806.; 29. Jo MW, Go DS, Kim R, et al. The burden of disease due to COVID-19 in Korea using disability-adjusted life years. J Korean Med Sci. 2020;35(21):e199.; 30. Moran D, Pires SM, Wyper G, Devleesschauwer B, Cuschieri S, Kabir Z. Estimating the direct disability-adjusted life years (DALYs) associated with SARSCoV-2 (COVID-19) in the Republic of Ireland: the first full year. Int J Public Health. 2022;67:1604699.; 31. Bonanad C, García-Blas S, Tarazona-Santabalbina F, et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915–918.; 32. Perez-Saez J, Lauer SA, Kaiser L, et al. Serology-informed estimates of SARSCoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2020;21(4):e69–e70.; 33. Rommel A, Lippe EV, Plass D, et al. The COVID-19 disease burden in Germany in 2020-years of life lost to death and disease over the course of the pandemic. Dtsch Ärztebl Int. 2021;118(9):145–151.; 34. Pifarré, Arolas H, Acosta E, López-Casasnovas G, et al. Years of life lost to COVID-19 in 81 countries [published correction appears in Sci Rep. 2021;11(1):8543]. Sci Rep. 2021;11(1):3504.; 35. Salinas-Escudero G, Toledano-Toledano F, García-Peña C, Parra-Rodríguez L, Granados-García V, Carrillo-Vega MF. Disability-adjusted life years for the COVID-19 pandemic in the Mexican population. Front Public Health. 2021;9: 686700.; 36. Andersen LM, Harden SR, Sugg MM, Runkle JD, Lundquist TE. Analyzing the spatial determinants of local COVID-19 transmission in the United States. Sci Total Environ. 2021;754:142396.; 37. Bialek S, Bowen V, Chow N. Geographic differences in COVID-19 cases, deaths, and incidence — United States, February 12-April 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):465–471.; 38. Jamshidi S, Baniasad M, Niyogi D. Global to USA county scale analysis of weather, urban density, mobility, homestay, and mask use on COVID-19. Int J Environ Res Public Health. 2020;17(21):7847.; 39. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171–177.; 40. Angulo FJ, Finelli L, Swerdlow DL. Estimation of US SARS-CoV-2 infections, symptomatic infections, hospitalizations, and deaths using seroprevalence surveys. JAMA Netw Open. 2021;4(1):e2033706.; 41. Lau H, Khosrawipour T, Kocbach P, Ichii H, Bania J, Khosrawipour V. Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters. Pulmonology. 2021;27(2):110–115.; 42. Wyper G, Fletcher E, Grant I, et al. Measuring disability-adjusted life years (DALYs) due to COVID-19 in Scotland, 2020. Arch Public Health. 2022;80(1):105.; 43. Asdaq SMB, Rabbani SI, Alshammari MK, et al. Burden of COVID-19: a preliminary analysis in the population of Saudi Arabia. PeerJ. 2022;10:e13219.; 44. Moran DP, Pires SM, Wyper GMA, Devleesschauwer B, Cuschieri S, Kabir Z. Estimating the direct disability-adjusted life years associated with SARS-CoV2 (COVID-19) in the Republic of Ireland: the first full year. Int J Public Health. 2022;67:1604699.; 45. Pires SM, Redondo HG, Espenhain L, et al. Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic. BMC Public Health. 2022;22(1):1315.; 46. Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70.; 47. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Longterm effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.; 48. Maglietta G, Diodati F, Puntoni M, et al. Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J Clin Med. 2022;11(6):1541.; 49. Sigfrid L, Drake TM, Pauley E, et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186.; 50. Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 - a systematic review. Brain Behav Immun. 2021;97:328–348.; 51. Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252–260.; 52. Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55.; 53. Moghadas SM, Moghadas SM, Vilches TN, et al. The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clin Infect Dis. 2021;73(12):2257–2264.; 17; 37; https://hdl.handle.net/11323/10509Test; Corporación Universidad de la Costa; REDICUC - Repositorio CUC; https://repositorio.cuc.edu.coTest/
DOI: 10.1016/j.vhri.2023.03.005
الإتاحة: https://doi.org/10.1016/j.vhri.2023.03.005Test
https://doi.org/10.1101/2020.05.24.20111765Test
https://hdl.handle.net/11323/10509Test
https://repositorio.cuc.edu.coTest/
حقوق: r ª 2023 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc. ; Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) ; https://creativecommons.org/licenses/by-nc-nd/4.0Test/ ; info:eu-repo/semantics/embargoedAccess ; http://purl.org/coar/access_right/c_f1cfTest
رقم الانضمام: edsbas.DB626FC7
قاعدة البيانات: BASE
الوصف
تدمد:22121099
22121102
DOI:10.1016/j.vhri.2023.03.005